Document › Details
Redbiotec AG. (6/20/13). "Press Release: Geneart Founder at Redbiotec". Schlieren.
|Organisation 2||Geneart AG|
|Today||Thermo Fisher Scientific Geneart GmbH|
|Group||Thermo Fisher (Group)|
|Product||VLP technology (virus-like particle technology)|
|Person||Wagner, Ralf (Lophius 201301– Managing Director before Geneart AG 1999– founder + CEO + CSO)|
Redbiotec AG announces today the appointment of Prof. Dr. Ralf Wagner, founder of Geneart, to Redbiotec's team. We are both proud and pleased that Dr. Wagner joined our Company as scientific advisor. With his strong background in synthetic biology and vaccines he will strengthen our leading position in VLP vaccines. In addition to his scientific background, Ralf Wagner has a notable track record as entrepreneur. In 1999 he co-founded Geneart and brought it public to the German stock market in 2006, followed by a successful tradesale of Geneart to the US company Life Technologies (formerly Invitrogen) in 2010. Redbiotec is convinced that it will profit a lot from Ralf Wagner in the continuation of its leading business.
Record changed: 2016-03-20
More documents for Redbiotec AG
-  Pfizer Inc.. (1/5/15). "Press Release: Pfizer Acquires Redvax GmbH. Acquisition Provides Pfizer with a Preclinical CMV Vaccine Candidate"....
-  Redbiotec AG. (12/3/13). "Press Release: Collaboration with GSK Vaccines". Schlieren....
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)